EcoDrugPlus

Atpase Na+/k+ Transporting Subunit Beta 1

Ensembl ID : ENSPVAG00000007351
Gene Symbol: ATP1B1
1 Cross references
295 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 2

Ensembl ID : ENSPVAG00000016314
Gene Symbol: ATP1B2
1 Cross references
274 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 3

Ensembl ID : ENSPVAG00000003326
Gene Symbol: ATP1B3
1 Cross references
299 Possible Orthologues:

Atr Serine/threonine Kinase

Ensembl ID : ENSPVAG00000016273
Gene Symbol: ATR
1 Cross references
206 Possible Orthologues:

B-Raf Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSPVAG00000015737
Gene Symbol: BRAF
1 Cross references
220 Possible Orthologues:

Bcl2 Apoptosis Regulator

Ensembl ID : ENSPVAG00000000125
Gene Symbol: BCL2
1 Cross references
227 Possible Orthologues:

Bcl2 Like 1

Ensembl ID : ENSPVAG00000006112
Gene Symbol: BCL2L1
1 Cross references
286 Possible Orthologues:

Bcl2 Like 10

Ensembl ID : ENSPVAG00000015836
Gene Symbol: BCL2L10
1 Cross references
129 Possible Orthologues:

Bcl2 Like 2

Ensembl ID : ENSPVAG00000005269
Gene Symbol: BCL2L2
1 Cross references
64 Possible Orthologues:

Bcl2 Related Protein A1

Ensembl ID : ENSPVAG00000006051
Gene Symbol: BCL2A1
1 Cross references
114 Possible Orthologues:

Bcr Activator Of Rhogef And Gtpase

Ensembl ID : ENSPVAG00000011395
Gene Symbol: BCR
1 Cross references
274 Possible Orthologues:

Bruton Tyrosine Kinase

Ensembl ID : ENSPVAG00000001567
Gene Symbol: BTK
1 Cross references
207 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).